Abnormalities of retinoblastoma gene expression in hematological malignancies (Q40958157)

25 September 2017

1 reference

title

Abnormalities of retinoblastoma gene expression in hematological malignancies (English)

1 reference

25 September 2017

1 reference

Zhu YM

1

1 reference

25 September 2017

Haynes AP

series ordinal

2

1 reference

25 September 2017

Keith FJ

series ordinal

3

1 reference

25 September 2017

Russell NH

series ordinal

4

1 reference

25 September 2017

1 June 1995

1 reference

25 September 2017

1 reference

25 September 2017

18

1 reference

25 September 2017

1-2

1 reference

25 September 2017

61-67

1 reference

A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma

25 September 2017

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Human retinoblastoma susceptibility gene: cloning, identification, and sequence.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Structural evidence for the authenticity of the human retinoblastoma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Structure of the human retinoblastoma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

The retinoblastoma protein is phosphorylated during specific phases of the cell cycle

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

The retinoblastoma susceptibility gene product undergoes cell cycle-dependent dephosphorylation and binding to and release from SV40 large T.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Cell cycle. Dams and sluices.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Phosphorylation of the retinoblastoma protein by cdk2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

TGF beta inhibition of Cdk4 synthesis is linked to cell cycle arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

E2F: a link between the Rb tumor suppressor protein and viral oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Functional interactions of the retinoblastoma protein with mammalian D-type cyclins

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Negative regulation of human c-fos expression by the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Regulation of transforming growth factor beta 1 gene expression by the product of the retinoblastoma-susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Suppression of tumorigenicity of human prostate carcinoma cells by replacing a mutated RB gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Suppression of the neoplastic phenotype by replacement of the RB gene in human cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

SV40 large tumor antigen forms a specific complex with the product of the retinoblastoma susceptibility gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

The human papilloma virus-16 E7 oncoprotein is able to bind to the retinoblastoma gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Identification of germline and somatic mutations affecting the retinoblastoma gene

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Frequent inactivation of the retinoblastoma anti-oncogene is restricted to a subset of human tumor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Promoter deletion and loss of retinoblastoma gene expression in human prostate carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Abnormalities in structure and expression of the human retinoblastoma gene in SCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Inactivation of the retinoblastoma susceptibility gene in human breast cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Retinoblastoma gene deletions in B-cell chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Inactivation of the retinoblastoma susceptibility gene in a human high grade non-Hodgkin's lymphoma cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Autonomous proliferation of leukemic cells in vitro as a determinant of prognosis in adult acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Heterogeneous mechanisms of autocrine growth of AML blasts.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Participation of the cytokines interleukin 6, tumor necrosis factor-alpha, and interleukin 1-beta secreted by acute myelogenous leukemia blasts in autocrine and paracrine leukemia growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Autocrine growth factors and leukaemic haemopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Somatic inactivation of genes on chromosome 13 is a common event in retinoblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F10428199509064923

10.3109/10428199509064923

21 January 2018

Identifiers

DOI

1 reference

25 September 2017

1 reference